Title |
Long noncoding RNAs and Alzheimer's disease
|
---|---|
Published in |
Clinical Interventions in Aging, June 2016
|
DOI | 10.2147/cia.s107037 |
Pubmed ID | |
Authors |
Qiong Luo, Yinghui Chen |
Abstract |
Long noncoding RNAs (lncRNAs) are typically defined as transcripts longer than 200 nucleotides. lncRNAs can regulate gene expression at epigenetic, transcriptional, and posttranscriptional levels. Recent studies have shown that lncRNAs are involved in many neurological diseases such as epilepsy, neurodegenerative conditions, and genetic disorders. Alzheimer's disease is a neurodegenerative disease, which accounts for >80% of dementia in elderly subjects. In this review, we will highlight recent studies investigating the role of lncRNAs in Alzheimer's disease and focus on some specific lncRNAs that may underlie Alzheimer's disease pathophysiology and therefore could be potential therapeutic targets. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
France | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | <1% |
Unknown | 131 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 26 | 20% |
Researcher | 23 | 17% |
Student > Bachelor | 16 | 12% |
Student > Ph. D. Student | 13 | 10% |
Student > Doctoral Student | 7 | 5% |
Other | 14 | 11% |
Unknown | 33 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 47 | 36% |
Agricultural and Biological Sciences | 20 | 15% |
Neuroscience | 10 | 8% |
Medicine and Dentistry | 9 | 7% |
Computer Science | 3 | 2% |
Other | 7 | 5% |
Unknown | 36 | 27% |